4SC AG Год IPO
Что обозначает Год IPO в 4SC AG?
Год IPO 4SC AG является 2005
Какое определение для Год IPO?
Первичное публичное размещение акций - это тип публичного предложения, при котором акции компании обычно продаются институциональным инвесторам, которые, в свою очередь, впервые продают эти акции широкой публике на фондовой бирже.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Год IPO компаний в Health Care сектор на XETRA по сравнению с 4SC AG
Что делает 4SC AG?
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany.
Компании с год ipo похож на 4SC AG
- Rurelec PLC имеет Год IPO из 2004
- Kona Bay Technologies имеет Год IPO из 2004
- FE Investments имеет Год IPO из 2004
- JBF Industries имеет Год IPO из 2004
- Indiabulls Ventures имеет Год IPO из 2004
- Alexion Pharmaceuticals имеет Год IPO из 2004
- 4SC AG имеет Год IPO из 2005
- Compass Diversified имеет Год IPO из 2006
- Green Plains Inc имеет Год IPO из 2006
- Catalyst Pharmaceuticals Inc имеет Год IPO из 2006
- Greatland Gold Plc имеет Год IPO из 2006
- Capital Environment имеет Год IPO из 2006
- Athena Resources имеет Год IPO из 2006